Hiroki Hosoi

Wakayama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 78 publications

Prognostic factors of second allogeneic hematopoietic stem cell transplantation for relapsed or refractory myelodysplastic syndromes: nationwide registry analysis.

Prognostic factors of second allogeneic hematopoietic stem cell transplantation for relapsed or refractory myelodysplastic syndromes: nationwide registry analysis.

Journal: Bone marrow transplantation

Published: May 19, 2026

Detection of BRAF V600E on the Re-evaluation in Erdheim-Chester Disease with Prior Negative Testing.

Detection of BRAF V600E on the Re-evaluation in Erdheim-Chester Disease with Prior Negative Testing.

Journal: Internal medicine (Tokyo, Japan)

Published: April 01, 2026

Bidirectional associations between bacteremia and cytomegalovirus infection after allogeneic hematopoietic cell transplantation: JSTCT Transplant Complications Working Group.

Bidirectional associations between bacteremia and cytomegalovirus infection after allogeneic hematopoietic cell transplantation: JSTCT Transplant Complications Working Group.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: March 16, 2026

Quizartinib Resistance Mutations and Treatment Outcomes in Relapsed or Refractory FLT3-ITD-Positive AML.

Quizartinib Resistance Mutations and Treatment Outcomes in Relapsed or Refractory FLT3-ITD-Positive AML.

Journal: Cancer science

Published: March 09, 2026

Distribution of CD30-positive tumor cell proportions in adult T-cell leukemia/lymphoma.

Distribution of CD30-positive tumor cell proportions in adult T-cell leukemia/lymphoma.

Journal: Leukemia & lymphoma

Published: February 03, 2026

Molecular targeted therapy for Erdheim-Chester disease

Molecular targeted therapy for Erdheim-Chester disease

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: November 05, 2025

Lineage switch from B-ALL to AML via an intervening MDS/MPN phase with acquisition of RBM15::MKL1 and RAD21 mutation.

Lineage switch from B-ALL to AML via an intervening MDS/MPN phase with acquisition of RBM15::MKL1 and RAD21 mutation.

Journal: Leukemia & lymphoma

Published: October 31, 2025

Genetic analysis of cell-free DNA in follicular lymphoma in comparison with tissue-derived DNA.

Genetic analysis of cell-free DNA in follicular lymphoma in comparison with tissue-derived DNA.

Journal: Leukemia & lymphoma

Published: October 15, 2025

Letermovir prophylaxis and risk of bacterial or fungal infection after allogeneic hematopoietic cell transplantation.

Letermovir prophylaxis and risk of bacterial or fungal infection after allogeneic hematopoietic cell transplantation.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: September 08, 2025

Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron era.

Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron era.

Journal: Frontiers in oncology

Published: August 17, 2025

Obinutuzumab-induced Acute Thrombocytopenia Mimicking Immune Thrombocytopenia in a Patient with Follicular Lymphoma.

Obinutuzumab-induced Acute Thrombocytopenia Mimicking Immune Thrombocytopenia in a Patient with Follicular Lymphoma.

Journal: Internal medicine (Tokyo, Japan)

Published: April 13, 2025

Survival outcomes and risk factors of second allogeneic hematopoietic cell transplantation in non-remission status for acute myeloid leukemia.

Survival outcomes and risk factors of second allogeneic hematopoietic cell transplantation in non-remission status for acute myeloid leukemia.

Journal: Bone marrow transplantation

Published: February 14, 2025

Showing 1-12 of 78

Last Updated: 09/26/2026